About Cysteine protease ATG4C
Cysteine protease ATG4C (ATG4C) is a protein
from Homo sapiens identified by UniProt accession
Q96DT6, 458 residues long.
MolForge cross-references it against 0 known binders and
95 disease associations.
Target properties
| Protein name | Cysteine protease ATG4C |
| UniProt accession | Q96DT6 |
| Gene | ATG4C |
| Organism | Homo sapiens |
| Length | 458 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (95)
Diseases linked to this target (Open Targets).
- sex hormone-binding globulin measurement · score 0.42
- triglyceride measurement · score 0.26
- total cholesterol measurement · score 0.26
- breast adenocarcinoma · score 0.18
- aspartate aminotransferase measurement · score 0.13
- pancreatic adenocarcinoma · score 0.10
- lymphatic system disease · score 0.09
- heart failure · score 0.09
- hypertension · score 0.09
- response to xenobiotic stimulus · score 0.09
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q96DT6-F1 | alphafold | PREDICTED | 79.78 | — |
Amino-acid sequence (458 residues)
MEATGTDEVD KLKTKFISAW NNMKYSWVLK TKTYFSRNSP VLLLGKCYHF KYEDEDKTLP AESGCTIEDH VIAGNVEEFR KDFISRIWLT YREEFPQIEG SALTTDCGWG CTLRTGQMLL AQGLILHFLG RAWTWPDALN IENSDSESWT SHTVKKFTAS FEASLSGERE FKTPTISLKE TIGKYSDDHE MRNEVYHRKI ISWFGDSPLA LFGLHQLIEY GKKSGKKAGD WYGPAVVAHI LRKAVEEARH PDLQGITIYV AQDCTVYNSD VIDKQSASMT SDNADDKAVI ILVPVRLGGE RTNTDYLEFV KGILSLEYCV GIIGGKPKQS YYFAGFQDDS LIYMDPHYCQ SFVDVSIKDF PLETFHCPSP KKMSFRKMDP SCTIGFYCRN VQDFKRASEE ITKMLKFSSK EKYPLFTFVN GHSRDYDFTS TTTNEEDLFS EDEKKQLKRF STEEFVLL
Explore Cysteine protease ATG4C with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets